Drug-induced anaemias

Area of Science:

• Hematology
• Pharmacology
• Toxicology

Background:

• Anemia is a known side effect of numerous pharmaceutical agents.
• Drug-induced anemia presents in various forms, including aplastic anemia, megaloblastic anemia, and sideroblastic anemia.
• The precise mechanisms underlying some drug-induced anemias, particularly aplastic anemia, remain unclear.

Purpose of the Study:

• To review the known causes and mechanisms of drug-induced anemia.
• To highlight the different types of anemia associated with drug use.
• To discuss the implications for clinical practice and patient management.

Main Methods:

• Literature review of reported cases and studies on drug-induced anemia.
• Analysis of mechanisms, including interference with dihydrofolate reductase and other pathways.
• Categorization of anemia types based on clinical presentation and etiology.

Main Results:

• Certain drugs cause megaloblastic anemia via dihydrofolate reductase inhibition, while others, like anticonvulsants, use alternative mechanisms.
• Intestinal bleeding induced by drugs is a common cause of anemia.
• Sideroblastic anemia can be drug-induced, notably by antitubercular agents.
• Leukemia is a rare but serious potential complication of drug-induced aplastic anemia.

Conclusions:

• Drug-induced anemias are diverse, with varied underlying mechanisms.
• Further research is needed to elucidate the pathogenesis of drug-induced aplastic anemia.
• Awareness of drug-associated anemia is essential for diagnosis and treatment.